GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: ANGO
Buy $14.50

Angiodynamics, Inc. (NASDAQ: ANGO) reiterated to Buy with price target $14.50 by Canaccord Genuity

Friday,  Jan 8, 2016  8:25 AM ET by Betsy O'Brien Harrison

Canaccord Genuity reiterated Angiodynamics, Inc. (NASDAQ: ANGO) to Buy with price target
$14.50. Previously Canaccord Genuity reiterated Angiodynamics, Inc. (NASDAQ: ANGO) to Buy with price target $20 on 06/19/2014, when the stock price was $16.00.

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and treatment of peripheral vascular disease. AngioDynamics, Inc. designs, develops, manufactures and markets a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. The Company's diverse product line includes angiographic products and accessories, dialysis products, vascular access products, PTA products, drainage products, thrombolytic products and venous products.

Canaccord Genuity’s global team of over 100 research professionals are inquisitive, experienced and committed to generating actionable investment ideas. We analyze over 725 companies in a broad range of market sectors, identifying value and defining risk for our clients.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy